Inhibrx grants director 10,000 options at $95.22
Amended Form 4 for INBX corrects a director’s option grant to 10,000 options at a $95.22 exercise price, vesting in 2027.
Rhea-AI Filing Summary
Inhibrx Biosciences, Inc. (INBX) reports that director Douglas Forsyth received a grant of 10,000 stock options on June 3, 2026, as corrected in this amended Form 4. The options have an exercise price of $95.22 per share and cover 10,000 shares of common stock.
The options become fully exercisable on June 3, 2027, subject to Mr. Forsyth’s continued service through that date, and expire on June 3, 2036. Following this grant, Mr. Forsyth holds 10,000 options directly. No Rule 10b5-1 trading plan is reported in connection with this grant.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 10,000 shares
Grant/Award
1 txn
Insider
FORSYTH DOUGLAS
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) F1 | 10,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 10,000 contracts (Direct)
Footnotes (1)
- F1. This stock option will be fully exercisable on June 3, 2027, subject to the reporting person's continued service through such date.
Key Figures
Stock options granted: 10,000 options
Exercise price: $95.22 per share
Underlying common shares: 10,000 shares
+3 more
6 metrics
Stock options granted
10,000 options
Grant to director Douglas Forsyth on June 3, 2026
Exercise price
$95.22 per share
Exercise price of the 10,000 stock options granted
Underlying common shares
10,000 shares
Shares of common stock underlying the granted options
Total options held after grant
10,000 options
Director’s direct holdings following the reported grant
Vesting (full exercisability) date
June 3, 2027
Date the options become fully exercisable, subject to continued service
Option expiration date
June 3, 2036
Expiration date of the granted stock options
Key Terms
stock option, exercise price, expiration date, Rule 10b5-1
4 terms
stock option financial
"This stock option will be fully exercisable on June 3, 2027"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
exercise price financial
"Stock options granted with an exercise price of $95.22 per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"The options have an expiration date of June 3, 2036"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
Rule 10b5-1 regulatory
"No Rule 10b5-1 trading plan is reported in connection with this grant"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did INBX report in this amended Form 4?
Inhibrx Biosciences reported that director Douglas Forsyth received a grant of 10,000 stock options on June 3, 2026, covering 10,000 shares of common stock at an exercise price of $95.22 per share.
Why was this Form 4/A filed for INBX?
The amended Form 4 was filed to correct the number of options granted to director Douglas Forsyth, which was misstated in the original Form 4 due to an administrative error. This amendment restates the original Form 4 in its entirety.
When do Douglas Forsyth’s INBX options vest and become exercisable?
The stock option grant to Douglas Forsyth will be fully exercisable on June 3, 2027, and this vesting is subject to his continued service with Inhibrx Biosciences through that date.
What is the exercise price and expiration date of the INBX options granted?
The 10,000 stock options granted to Douglas Forsyth have an exercise price of $95.22 per share and an expiration date of June 3, 2036, if not exercised earlier in accordance with the option terms.
How many INBX options does Douglas Forsyth hold after this grant?
Following this grant, Douglas Forsyth holds 10,000 stock options directly. These options are for 10,000 shares of Inhibrx Biosciences common stock and become fully exercisable on June 3, 2027.
Was a Rule 10b5-1 trading plan used for this INBX option grant?
No. The filing indicates that no Rule 10b5-1 trading plan applies to this transaction; it is reported simply as a grant of stock options to a director.
AI-generated analysis. How Rhea-AI works. Not financial advice.
